Enforcement record
承認 against 日本イーライリリー株式会社
This page is one enforcement record. Company-level Official Gazette notices, registry data, related-company signals, and other public records are collected on the company profile.
View company profileAction type
承認
Law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
Authority
Ministry of Health, Labour and Welfare
Action date
23 April 2021
RegBase evidence report
Japanese public-record enforcement check
Saveable record of the target entity, regulator disclosure, source status, and review notes for internal compliance files.
- Report ID
- RB-EN-ENFORCEMENT-OTHER-RI-BEN-IRAI-202607080643
- Generated at
- 8 July 2026 at 15:43
- Record URL
- https://regbase.jp/en/enforcement/other-ri-ben-irairiri-20210423
1. Review Summary
| Target entity | 日本イーライリリー株式会社 | Corporate Number | 3140001012176 |
|---|---|---|---|
| Enforcement record | 1 record | Other records for this company | 0 records |
| Action date | 23 April 2021 | Authority | Ministry of Health, Labour and Welfare |
| Law | Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices | Action type | 承認 |
| Source status | Original-source archive or viewer URL recorded | ||
This report summarizes public Japanese government disclosure data held by RegBase. It is not a credit score, sanctions conclusion, legal opinion, or adverse-media determination. Confirm important decisions against the linked official Japanese source.
2. Target Entity
| English display name | 日本イーライリリー株式会社 |
|---|---|
| Original Japanese name | 日本イーライリリー株式会社 |
| English-name source | Japanese original |
| Corporate Number | 3140001012176 |
| Company status | Active |
| Representative | Not recorded |
| Registered address | 兵庫県神戸市中央区磯上通5丁目1番28号 |
| Industry / capital | Industry: 医薬品 / Capital: - |
3. Enforcement Record
| Target name in disclosure | 日本イーライリリー株式会社 |
|---|---|
| Authority | Ministry of Health, Labour and Welfare (厚生労働省) |
| Law / action type | Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices / 承認 |
| Action / announcement date | Action: 23 April 2021 / Announcement: 8 April 2026 |
| English summary | Indications and effects to be added: Pneumonia caused by SARS-CoV-2 (limited to patients requiring oxygen inhalation). |
| Original Japanese text | 追加する効能・効果:SARS-CoV-2による肺炎(ただし、酸素吸入を要する患者に限る) |
| Official source | https://www.mhlw.go.jp/stf/newpage_18199.html |
| Source archive | https://kiroku.today/a/6bcf071631qcv0mw |
| Extraction / evidence timestamps | Extracted: 25 April 2026 at 09:17 / Evidence checked: 25 April 2026 at 09:17 / Archive captured: 9 April 2026 at 03:02 |
4. Business Location and Permit Details
No additional structured business-location or permit fields are recorded for this disclosure.
5. Other Records for This Company
No other enforcement records linked to this company are shown within the current RegBase coverage.
Reviewer Notes
| Reviewer | Team / company | ||
|---|---|---|---|
| Review purpose | |||
| Additional notes | |||
- □ Official source URL or archived source was checked.
- □ Corporate Number, address, or other identifiers were reviewed to avoid confusing similarly named entities.
- □ This document is understood as a public-record evidence file, not a credit decision or legal opinion.
Current page: Enforcement record
This screen focuses on one disclosed action: governing law, authority, facts, source status, and review evidence. Open the company profile for company-level registry, Official Gazette, and related-company context.
Free report
Save a public-record evidence report for 日本イーライリリー株式会社
Includes target-entity identifiers, regulator, governing law, source links, archive status, and reviewer note fields for internal due-diligence files.
Related tool Kiroku
Track website changes for 日本イーライリリー株式会社
After checking public records, use Kiroku to save and monitor official websites, terms, IR pages, pricing pages, announcements, and other URLs that may change over time.
For developers: JSON integration details
You do not need this for normal browsing. Use it only when integrating this enforcement record into an internal tool or AI workflow.
Action summary
- Company
- 日本イーライリリー株式会社Japanese originalOriginal: 日本イーライリリー株式会社Corporate Number: 3140001012176
- Entity match
- Confirmed entity match95/100Machine extractedNormalized Japanese name matched to a company profile with Corporate NumberMatched by normalized Japanese company name to an enriched company profile with a Corporate Number.
- Governing law
- Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices医薬品医療機器等法
- Action type
- 承認承認
- Action date
- 23 April 2021
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
- Industry context
- 医薬品
Violation
Indications and effects to be added: Pneumonia caused by SARS-CoV-2 (limited to patients requiring oxygen inhalation).
Show original Japanese text
追加する効能・効果:SARS-CoV-2による肺炎(ただし、酸素吸入を要する患者に限る)
Compliance context
Context neededThis is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.
Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices.
Review the original Japanese source and determine relevance to your counterparty-risk workflow.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-25T00:17:36.717+00:00
- Evidence checked
- 2026-04-25T00:17:36.717+00:00
- Archive captured
- 2026-04-08T18:02:07.045+00:00
Show audit JSON
{
"record": {
"id": "5eb15186-a1fc-473c-9232-c4c35010ea6e",
"url": "https://regbase.jp/en/enforcement/other-ri-ben-irairiri-20210423",
"company_name_original": "日本イーライリリー株式会社",
"company_name_registry": "日本イーライリリー株式会社",
"corporate_number": "3140001012176",
"law": {
"ja": "医薬品医療機器等法",
"en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
},
"action_type": {
"ja": "承認",
"en": "承認"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "confirmed",
"confidence": 95,
"method": "normalized_name_with_corporate_number",
"method_label": "Normalized Japanese name matched to a company profile with Corporate Number",
"notes": "Matched by normalized Japanese company name to an enriched company profile with a Corporate Number."
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Context needed",
"actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
"practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
"lawContext": "Japanese regulatory disclosure under Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-ri-ben-irairiri-20210423",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_18199.html",
"archiveUrl": "https://kiroku.today/view/6bcf071631qcv0mw",
"archiveCapturedAt": "2026-04-08T18:02:07.045+00:00",
"extractedAt": "2026-04-25T00:17:36.717+00:00",
"translatedAt": "2026-05-01T07:06:40.25+00:00",
"evidenceCheckedAt": "2026-04-25T00:17:36.717+00:00",
"generatedAt": "2026-07-08T06:43:45.351Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)Company info
- English name
- 日本イーライリリー株式会社 Japanese original
- Japanese name
- 日本イーライリリー株式会社
- Corporate Number
- 3140001012176
- Registered address
- 兵庫県神戸市中央区磯上通5丁目1番28号
Recent records in the same industry
- 緊急承認22 Nov 2022
塩野義製薬株式会社
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
- 承認12 Sept 2022
モデルナ・ジャパン株式会社
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
- 承認12 Sept 2022
ファイザー株式会社
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
- 承認12 Sept 2022
ファイザー株式会社
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
- 承認12 Sept 2022
モデルナ・ジャパン株式会社
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.